Literature DB >> 469929

Passive protection by human serum in mice infected with encapsulated Staphylococcus aureus.

K Yoshida, Y Ichiman, S Narikawa, M Takahashi, E Kono, C L San Clemente.   

Abstract

The occurrence and nature of passive protective antibody in 100 samples of human serum was investigated in mice challenged with strains of Staphylococcus aureus capsular types A (Smith diffuse strain) and B (strain NS58D). Sixty of the sera passively protected mice against the capsular type-A strain, three against type B, and one against both types. Rabbit antisera against human IgG, IgA and IgM could remove the protective activity from a human serum of high potency, and the activity was also sensitive to 2-mercaptoethanol. Absorption with Smith surface antigen removed protective activity and reduced the concentration of IgG 7-fold, IgA 2.7 fold and of IgM 3-fold more than in a non-protective serum. Consequently, the protective activity of human serum is believed to be associated with antibodies to the S. aureus capsular antigen in the three immunoglobulin classes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 469929     DOI: 10.1099/00222615-12-3-277

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Passive protection by human sera in mice against challenge with strains of group B streptococci.

Authors:  Y Ichiman; K Yoshida
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Synergistic effect of rabbit specific antiserum and amikacin on the treatment of mice with lethal infection due to Klebsiella pneumoniae.

Authors:  K Yoshida; M Takahashi; S Narikawa
Journal:  Experientia       Date:  1981

3.  Successive extraction of specific protective immunoglobulins from pooled human sera.

Authors:  K Yoshida; Y Ichiman
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

Authors:  A I Fattom; J Sarwar; A Ortiz; R Naso
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

5.  Human specific immunoglobulin protects against infection with common Staphylococcus in mice.

Authors:  K Yoshida; Y Ichiman; Y Ohshima
Journal:  Experientia       Date:  1987-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.